Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Volume 2, 2011

Volume 2, Issue 1-2 pp 1-101	Volume 2, Issue 3 pp 102-270	Volume 2, Issue 4 pp 271-351	Volume 2, Issue 5 pp 352-427	Volume 2, Issue 6 pp 428-524
Volume 2, Issue 7 pp 525-586	Volume 2, Issue 8 pp 587-653	Volume 2, Issue 9 pp 654-736	Volume 2, Issue 10 pp 737-819	Volume 2, Issue 11 pp 820-891
Volume 2, Issue 12 pp 892-1367

Publication Alerts

Post-Publication Promotion

Publication Discount

Volume 2, 2011